Dalton to manufacture DRDC antiviral agent
LE-Poly ICLC is an antiviral agent proven to be effective in animal studies against avian influenza virus, ebola and alphavirus infections. Under a sub-contract from Oncovir, Dalton established
Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to plasma-derived medicinal products (PDMPs).
The study has demonstrated the bioavailability enhancing properties of silica in humans, which enables active pharmaceutical ingredients to effectively absorb into the body. Grace New Business Development vice